Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase Expands Intellectual Property Portfolio

<< Previous

Bullboard Posts

Next >>

Comment by IvanVanBeethovenon Jun 28, 2022 10:22am

235 Views

Post# 34787248

RE:RE:RE:RE:New Press Release - Theralase Expands Intellectual Property Portfolio

Hi Lasershoes,

I know you've been fed up with it for a long time. But all I can say is that exceptional things take time to blossom. It has been a bumpy road so far, especially in the last few years of crisis.
So whenever I get frustrated, I tuck my case of Theralase red wine back away in the cellar, knowing it was an outstanding wine year when it was bottled, but still a bit too early to uncork a bottle!
Enjoy your salad. All the best.

regards
Ivan

<< Previous

Bullboard Posts

Next >>

Meet Canopy USA’s new CEO, Brooks Jorgensen